好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Neuroinvasive Spectrum of West Nile Virus.
Infectious Disease
P4 - Poster Session 4 (5:30 PM-6:30 PM)
4-038
To highlight the spectrum of Neuroinvasive disease of West Nile Virus (WNV) in a case series of five patients.

WNV is a neurotropic virus with predilection to brainstem, cerebellum and the anterior horn cells of the spinal cord. The mechanisms of neuroinvasion include entry into the central nervous system by direct infection of vascular endothelium. 

This is a case series of five patients admitted to our inpatient neurology service.

Case 1: 45-year-old woman presented with sudden onset fever and left (L) lower extremity (LLE) weakness. The strength of her LLE was 2/5 in all muscle groups and was areflexic.

Case 2: 68-year-old man presented with altered mental status and flaccid quadriplegic. His initial motor exam showed 0/5 strength in all 4 extremities and was areflexia.

Case 3: 56-year-old woman with history of pancreatic and renal transplant presented with altered mental status and lower extremity weakness severe in L >right (R).

On exam, distal strength in LLE was 1/5 and RLE was 3/5 with hyporeflexia.

Case 4: 36-year-old man presented with personality and behavioral changes with neuropsychiatric symptoms.

Case 5: 34-year-old woman with history renal transplant and presented with acute mental status changes. On examination, nystagmus and opsoclonus and bilateral lower extremity weakness with hyporeflexia.

CSF sample of three patients was positive for WNV IgM antibody, one patient was positive on Polymerase Chain Reaction and one patient was positive for IgG antibody.

Neuroinvasive variants in WNV is seen in less than 1% of those infected but the mortality can be up to 10%. Our case series highlights neuroinvasive spectrum of WNV disease ranging from acute segmental motor paresis, flaccid paralysis, acute rhombencephalitis and neuropsychiatric complications. These presentations should be considered during differential diagnosis and the presence of WNV IgM antibody in the CSF which is suggestive of acute infection.

 

Authors/Disclosures
Meghana S. Kinariwala, MD (Providence Neuroscience Instituite)
PRESENTER
Dr. Srinivas has nothing to disclose.
Shitiz K. Sriwastava, MBBS (UT Health Houston) Dr. Sriwastava has nothing to disclose.
Mihir Kakara, MD Dr. Kakara has nothing to disclose.
Maysaa M. Basha, MD, FAAN (Wayne State University, Detroit Medical Center) Dr. Basha has nothing to disclose.
Evanthia Bernitsas, MD, FAAN (Wayne State School of Medicine) Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.